- Home
- PCRX vs ECX Comparison
PCRX vs ECX Comparison
Compare PCRX & ECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- ECX
- Stock Information
- Founded
- PCRX 2006
- ECX 2017
- Country
- PCRX United States
- ECX China
- Employees
- PCRX N/A
- ECX N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- ECX EDP Services
- Sector
- PCRX Health Care
- ECX Technology
- Exchange
- PCRX Nasdaq
- ECX Nasdaq
- Market Cap
- PCRX 1.2B
- ECX 584.9M
- IPO Year
- PCRX 2011
- ECX N/A
- Fundamental
- Price
- PCRX $26.59
- ECX $1.68
- Analyst Decision
- PCRX Buy
- ECX
- Analyst Count
- PCRX 10
- ECX 0
- Target Price
- PCRX $29.30
- ECX N/A
- AVG Volume (30 Days)
- PCRX 892.8K
- ECX 1.0M
- Earning Date
- PCRX 02-27-2025
- ECX 02-26-2025
- Dividend Yield
- PCRX N/A
- ECX N/A
- EPS Growth
- PCRX N/A
- ECX N/A
- EPS
- PCRX N/A
- ECX N/A
- Revenue
- PCRX $694,957,000.00
- ECX $778,608,168.00
- Revenue This Year
- PCRX $5.14
- ECX $20.12
- Revenue Next Year
- PCRX $2.44
- ECX $32.70
- P/E Ratio
- PCRX N/A
- ECX N/A
- Revenue Growth
- PCRX 4.40
- ECX 25.45
- 52 Week Low
- PCRX $11.16
- ECX $0.96
- 52 Week High
- PCRX $31.67
- ECX $3.09
- Technical
- Relative Strength Index (RSI)
- PCRX 77.75
- ECX 35.40
- Support Level
- PCRX $25.06
- ECX $1.59
- Resistance Level
- PCRX $27.10
- ECX $1.79
- Average True Range (ATR)
- PCRX 1.45
- ECX 0.13
- MACD
- PCRX 0.28
- ECX -0.04
- Stochastic Oscillator
- PCRX 86.23
- ECX 3.44
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
About ECX ECARX Holdings Inc. Ordinary shares
ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services primarily in the People's Republic of China. The company's core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.